Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
James Shin is an analyst at Deutsche Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/18/2025 | GILD | Buy Now | Gilead Sciences | $106.63 | 12.54% | James Shin42% | $80 → $120 | Upgrade | Hold → Buy | Get Alert |
| 02/18/2025 | MRK | Buy Now | Merck & Co | $92.17 | 13.92% | James Shin42% | $128 → $105 | Downgrade | Buy → Hold | Get Alert |
| 11/04/2024 | LLY | Buy Now | Eli Lilly | $872.41 | 16.34% | James Shin42% | $1025 → $1015 | Maintains | Buy | Get Alert |
| 10/03/2024 | LLY | Buy Now | Eli Lilly | $872.41 | 17.49% | James Shin42% | $1025 → $1025 | Reiterates | Buy → Buy | Get Alert |
| 08/12/2024 | LLY | Buy Now | Eli Lilly | $872.41 | 17.49% | James Shin42% | $725 → $1025 | Upgrade | Hold → Buy | Get Alert |
| 08/07/2024 | AMGN | Buy Now | Amgen | $313.12 | -2.59% | James Shin42% | $310 → $305 | Reiterates | Hold → Hold | Get Alert |
| 08/01/2024 | INCY | Buy Now | Incyte | $62.88 | -4.59% | James Shin42% | $55 → $60 | Maintains | Hold | Get Alert |
| 07/23/2024 | BMY | Buy Now | Bristol-Myers Squibb | $61.16 | -26.43% | James Shin42% | $53 → $45 | Maintains | Hold | Get Alert |
| 05/23/2024 | LEGN | Buy Now | Legend Biotech | $36.04 | 66.48% | James Shin42% | → $60 | Initiates | → Buy | Get Alert |
| 05/23/2024 | INCY | Buy Now | Incyte | $62.88 | -12.54% | James Shin42% | → $55 | Initiates | → Hold | Get Alert |
| 11/09/2023 | LLY | Buy Now | Eli Lilly | $872.41 | -38.68% | James Shin42% | → $535 | Initiates | → Hold | Get Alert |
| 11/09/2023 | GILD | Buy Now | Gilead Sciences | $106.63 | -29.66% | James Shin42% | → $75 | Initiates | → Hold | Get Alert |
| 11/09/2023 | BMY | Buy Now | Bristol-Myers Squibb | $61.16 | -10.08% | James Shin42% | → $55 | Initiates | → Hold | Get Alert |
| 11/09/2023 | ABBV | Buy Now | AbbVie | $208.35 | -28.01% | James Shin42% | → $150 | Initiates | → Hold | Get Alert |
| 11/09/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $660.07 | 21.2% | James Shin42% | → $800 | Initiates | → Hold | Get Alert |
| 11/09/2023 | MRK | Buy Now | Merck & Co | $92.17 | 24.77% | James Shin42% | → $115 | Initiates | → Buy | Get Alert |
| 11/09/2023 | AMGN | Buy Now | Amgen | $313.12 | -23.35% | James Shin42% | → $240 | Initiates | → Hold | Get Alert |
| 11/09/2023 | IMGN | Buy Now | Immunogen | — | — | James Shin42% | → $25 | Initiates | → Buy | Get Alert |
| 11/09/2023 | AUTL | Buy Now | Autolus Therapeutics | $1.65 | 505.99% | James Shin42% | → $10 | Initiates | → Buy | Get Alert |
| 11/09/2023 | STRO | Buy Now | Sutro Biopharma | $0.78 | 1438.46% | James Shin42% | → $12 | Initiates | → Buy | Get Alert |
| 12/12/2022 | AFMD | Buy Now | Affimed | $0.88 | 695.45% | James Shin42% | $80 → $70 | Maintains | Overweight | Get Alert |
